Compare QSR & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QSR | WAT |
|---|---|---|
| Founded | 1954 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 33.5B |
| IPO Year | 2014 | 1996 |
| Metric | QSR | WAT |
|---|---|---|
| Price | $74.80 | $379.29 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 17 |
| Target Price | $81.35 | ★ $379.19 |
| AVG Volume (30 Days) | ★ 3.0M | 854.9K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | N/A | ★ 0.47 |
| EPS | ★ 0.97 | N/A |
| Revenue | ★ $9,434,000,000.00 | N/A |
| Revenue This Year | $5.34 | $104.66 |
| Revenue Next Year | $1.88 | $10.40 |
| P/E Ratio | $77.06 | ★ N/A |
| Revenue Growth | ★ 12.23 | N/A |
| 52 Week Low | $61.33 | $275.05 |
| 52 Week High | $81.96 | $414.15 |
| Indicator | QSR | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 53.27 | 62.63 |
| Support Level | $71.03 | $372.18 |
| Resistance Level | $76.90 | $388.97 |
| Average True Range (ATR) | 1.81 | 10.43 |
| MACD | 0.14 | 0.64 |
| Stochastic Oscillator | 64.71 | 90.01 |
Restaurant Brands generates about $47 billion in system sales across more than 33,000 restaurants in over 120 markets, making it one of the largest restaurant companies globally. Its banners include Burger King (7,025 stores), Tim Hortons (4,586), Popeyes (3,578), and Firehouse Subs (1,449), concentrated in the US and Canada, with these brands also comprising 16,403 franchised international locations as of year-end 2025. The firm primarily earns revenue from franchise and property fees, supply chain sales within the Tim Hortons segment, company-operated restaurants, and advertising royalties.
Waters sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. In early 2026, Waters merged with BD's life science and diagnostics business, which increased its concentration in diagnostics (versus none now) and discovery-related life science tools.